DK151340C - Analogifremgangsmaade til fremstilling af et krystallinsk cephalosporinderivat - Google Patents

Analogifremgangsmaade til fremstilling af et krystallinsk cephalosporinderivat

Info

Publication number
DK151340C
DK151340C DK385777A DK385777A DK151340C DK 151340 C DK151340 C DK 151340C DK 385777 A DK385777 A DK 385777A DK 385777 A DK385777 A DK 385777A DK 151340 C DK151340 C DK 151340C
Authority
DK
Denmark
Prior art keywords
crystallinic
preparing
analogy procedure
cephalosporine derivative
cephalosporine
Prior art date
Application number
DK385777A
Other languages
English (en)
Other versions
DK385777A (da
DK151340B (da
Inventor
Kenzo Naito
Kazuo Tsukamura
Haruo Sinbo
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK385777A publication Critical patent/DK385777A/da
Publication of DK151340B publication Critical patent/DK151340B/da
Application granted granted Critical
Publication of DK151340C publication Critical patent/DK151340C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK385777A 1976-08-31 1977-08-30 Analogifremgangsmaade til fremstilling af et krystallinsk cephalosporinderivat DK151340C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP51104583A JPS603314B2 (ja) 1976-08-31 1976-08-31 セフアロスポリン誘導体およびその製造法
JP10458376 1976-08-31

Publications (3)

Publication Number Publication Date
DK385777A DK385777A (da) 1978-03-01
DK151340B DK151340B (da) 1987-11-23
DK151340C true DK151340C (da) 1988-04-25

Family

ID=14384446

Family Applications (1)

Application Number Title Priority Date Filing Date
DK385777A DK151340C (da) 1976-08-31 1977-08-30 Analogifremgangsmaade til fremstilling af et krystallinsk cephalosporinderivat

Country Status (15)

Country Link
US (1) US4146710A (da)
JP (1) JPS603314B2 (da)
BE (1) BE858296A (da)
BG (1) BG60439B2 (da)
CA (1) CA1102310A (da)
CH (1) CH630088A5 (da)
DE (1) DE2738711C2 (da)
DK (1) DK151340C (da)
FR (1) FR2364922A1 (da)
GB (1) GB1589841A (da)
HK (1) HK27784A (da)
MY (1) MY8500266A (da)
NL (1) NL189355C (da)
NO (1) NO154015C (da)
SE (1) SE426069B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575803A (en) * 1976-03-09 1980-10-01 Fujisawa Pharmaceutical Co 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
US4189479A (en) * 1977-12-22 1980-02-19 Takeda Chemical Industries, Ltd. Cephalosporin esters
US4180658A (en) * 1978-02-24 1979-12-25 Bristol-Myers Company 7[-2-Alkoxyamino(acetamido)]cephalosporin derivatives
JPS5579393A (en) * 1978-12-11 1980-06-14 Takeda Chem Ind Ltd Cephalosporin derivative and its preparation
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
JPS58189186A (ja) * 1982-04-30 1983-11-04 Takeda Chem Ind Ltd セフアロスポリン誘導体
JPS63266177A (ja) * 1987-04-22 1988-11-02 Toyota Autom Loom Works Ltd 揺動斜板型圧縮機におけるコンロツドの連結方法
JPH06122630A (ja) * 1992-10-12 1994-05-06 Taiyo Yakuhin Kogyo Kk 安定な塩酸セフォチアム製剤
GB9503717D0 (en) * 1995-02-24 1995-04-12 Smithkline Beecham Plc Novel compounds
CN103601737B (zh) * 2013-12-04 2016-02-03 哈药集团制药总厂 一种盐酸头孢替安的制备方法
CN104926835B (zh) * 2015-06-24 2017-10-03 山东罗欣药业集团股份有限公司 一种盐酸头孢替安化合物、其制备方法及其药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho

Also Published As

Publication number Publication date
CH630088A5 (de) 1982-05-28
BG60439B2 (bg) 1995-03-31
HK27784A (en) 1984-03-30
BE858296A (fr) 1978-02-28
SE426069B (sv) 1982-12-06
DE2738711C2 (de) 1985-07-11
MY8500266A (en) 1985-12-31
DK385777A (da) 1978-03-01
FR2364922A1 (fr) 1978-04-14
NL189355B (nl) 1992-10-16
NO154015B (no) 1986-03-24
FR2364922B1 (da) 1981-07-31
NL189355C (nl) 1993-03-16
DE2738711A1 (de) 1978-03-02
GB1589841A (en) 1981-05-20
SE7709745L (sv) 1978-03-01
NO154015C (no) 1986-07-02
NL7709614A (nl) 1978-03-02
CA1102310A (en) 1981-06-02
NO772960L (no) 1978-03-01
JPS603314B2 (ja) 1985-01-26
US4146710A (en) 1979-03-27
JPS5329913A (en) 1978-03-20
DK151340B (da) 1987-11-23

Similar Documents

Publication Publication Date Title
DK271677A (da) Fremgangsmade til fremstilling af et farmaceutisk indsetningspreparat
DK565977A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycinsalte
DK81277A (da) Fremgangsmade til fremstilling af bis-pyridinium-forbindelser
DK147068C (da) Analogifremgangsmaade til fremstilling af 1-naphthylmethyl-cinnamyl-aminderivater
DK242176A (da) Fremgangsmade til fremstilling af et syntetisk hologram
DK161597C (da) Analogifremgangsmaade til fremstilling af polyprenylderivater
DK148059C (da) Analogifremgangsmaade til fremstilling af anthracyclinglycosidforbindelser
DK151340C (da) Analogifremgangsmaade til fremstilling af et krystallinsk cephalosporinderivat
DK117677A (da) Fremgangsmade til fremstilling af piperidinderivater
SE432250B (sv) Forfarande for framstellning av ett kinazolinderivat
DK123277A (da) Fremgangsmade til fremstilling af 3-halogenmethyl-3-cephem-forbindelser
DK566977A (da) Fremgangsmaade til fremstilling af polyenforbindelser
DK169378A (da) Fremgangsmaade til fremstilling af en oploesning
DK38577A (da) Fremgangsmade til fremstilling af betalactamholdige forbindelser
DK496277A (da) Fremgangsmaade til fremstilling af en blokpolyamidcopolymer
DK247877A (da) Fremgangsmade til fremstilling af klavamforbindelser
DK142848C (da) Analogifremgangsmaade til fremstilling af 2-acylamido-4-amino-5-benzylpyrimidinforbindelser
DK52877A (da) Fremgangsmade til fremstilling af en piperazinforbindelse
DK174876A (da) Fremgangsmade til fremstilling af et vaskepulver
DK471577A (da) Fremgangsmaade til fremstilling af clavamderivater
DK478277A (da) Fremgangsmaade til fremstilling af et polypeptid
DK581277A (da) Fremgangsmaade til fremstilling af cephalosporinforbindelser
DK371477A (da) Fremgangsmaade til fremstilling af et praeparat
DK141748C (da) Analogifremgangsmaade til fremstilling af et 4-ethynylbiphenylderivat
DK372577A (da) Fremgangsmaade til fremstilling af et 3-methyl-2-(4-halogenphenyl)-butyronitril

Legal Events

Date Code Title Description
PUP Patent expired